IDEAYA Biosciences (IDYA) Prepaid Assets (2018 - 2026)
IDEAYA Biosciences (IDYA) reported Prepaid Assets of $18.3 million for Q1 2026, up 19.41% on a YoY basis from $15.4 million in Q1 2025, and down 14.13% sequentially from $21.4 million in Q4 2025.
IDEAYA Biosciences (IDYA) Prepaid Assets (2018 - 2026) Analysis & Trends
IDEAYA Biosciences (IDYA) has 9 years of Prepaid Assets data on file, last reported at $18.3 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 19.41% year-over-year to $18.3 million; the trailing twelve-month figure through Mar 2026 stood at $18.3 million (up 19.41% YoY), and the FY2025 full-year result was $21.4 million, up 59.52% from the prior year.
- Prepaid Assets eased to $18.3 million in Q1 2026, from $21.4 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $21.4 million in Q4 2025 to a low of $2.8 million in Q1 2022.
- A 5-year average of $10.3 million and a median of $10.6 million in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets retreated 23.48% in 2022 and surged 162.84% in 2024, its largest moves.
- Tracing IDYA's Prepaid Assets over 5 years: stood at $5.4 million in 2022, then jumped by 38.53% to $7.5 million in 2023, then jumped by 78.59% to $13.4 million in 2024, then jumped by 59.52% to $21.4 million in 2025, then retreated by 14.13% to $18.3 million in 2026.
- Business Quant data shows IDYA's Prepaid Assets at $18.3 million in Q1 2026, $21.4 million in Q4 2025, and $15.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | IDEAYA Biosciences | 3.21 Bn | 2.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.35 Mn |
| Dec 31, 2025 | 21.37 Mn |
| Sep 30, 2025 | 15.76 Mn |
| Jun 30, 2025 | 15.86 Mn |
| Mar 31, 2025 | 15.36 Mn |
| Dec 31, 2024 | 13.39 Mn |
| Sep 30, 2024 | 12.17 Mn |
| Jun 30, 2024 | 11.52 Mn |
| Mar 31, 2024 | 10.57 Mn |
| Dec 31, 2023 | 7.50 Mn |
| Sep 30, 2023 | 6.73 Mn |
| Jun 30, 2023 | 7.91 Mn |
| Mar 31, 2023 | 4.02 Mn |
| Dec 31, 2022 | 5.41 Mn |
| Sep 30, 2022 | 3.74 Mn |
| Jun 30, 2022 | 3.28 Mn |
| Mar 31, 2022 | 2.75 Mn |
| Dec 31, 2021 | 3.12 Mn |
| Sep 30, 2021 | 3.39 Mn |
| Jun 30, 2021 | 4.29 Mn |